New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
HLS Therapeutics Inc.
HLTRF
Shape
US Flag

PNK

Unprofitable

Unprofitable

87M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

87M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

2.75USD
Shape0.06 ( 2.23%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-61%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

31%

Quote Panel

Shape
Updated October 23, 2024
1W -3.87 % 1M 5.00 % 3M 5.41 % 1Y -28.91 %

Key Metrics

Shape
  • Market Cap

    87.43M


  • Shares Outstanding

    31.79M


  • Share in Float

    31.55M


  • Dividende

    0.15


  • Earning Date

    07 Nov 2024


  • Price Target

    2.75


  • Average Volume

    257


  • Beta

    1.065


  • Range

    2.22-4.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.hlstherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.44x

P/S Ratio

1.04x

P/B Ratio

1.0

Debt/Equity

-40.8%

Net Margin

$-0.8

EPS

How HLTRF compares to sector?

P/E Ratio

Relative Strength

Shape

HLTRF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$64M

Shape340%

2025-Revenue

$0.34

Shape-89%

2025-EPS

$26M

Shape568%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.14
vs -0.06

Q4.22

arrow
arrow

N/A

-0.20
vs -0.13

Q1.23

arrow
arrow

N/A

-0.18
vs -0.11

Q2.23

arrow
arrow

N/A

-0.29
vs -0.28

Q3.23

arrow
arrow

N/A

-0.21
vs -0.14

Q4.23

arrow
arrow

N/A

-0.17
vs -0.20

Q1.24

arrow
arrow

N/A

-0.19
vs -0.18

Q2.24

arrow
arrow

N/A

-0.18
vs -0.29

Q3.24

arrow
arrow

N/A

-0.12
vs -0.21

Q4.24

arrow
arrow

N/A

-0.11
vs -0.17

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+4%

15.7M  vs 15.1M

Q4.22

arrow
arrow

0%

15.7M  vs 15.7M

Q1.23

arrow
arrow

+1%

14.8M  vs 14.6M

Q2.23

arrow
arrow

+6%

16.4M  vs 15.5M

Q3.23

arrow
arrow

+2%

16M  vs 15.7M

Q4.23

arrow
arrow

+4%

16.3M  vs 15.7M

Q1.24

arrow
arrow

-16%

12.4M  vs 14.8M

Q2.24

arrow
arrow

-12%

14.5M  vs 16.4M

Q3.24

arrow
arrow

-9%

14.6M  vs 16M

Q4.24

arrow
arrow

-3%

15.8M  vs 16.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.06

Q4.22

arrow
arrow

-5%

-0.05
vs -0.03

Q1.23

arrow
arrow

-5%

-0.05
vs -0.05

Q2.23

arrow
arrow

-8%

-0.08
vs -0.05

Q3.23

arrow
arrow

-7%

-0.07
vs -0.08

Q4.23

arrow
arrow

-6%

-0.06
vs -0.07

Q1.24

arrow
arrow

-7%

-0.07
vs -0.06

Q2.24

arrow
arrow

-7%

-0.07
vs -0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News